Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer.
Koppikar S, Oaknin A, Babu KG, Lorusso D, Gupta S, Wu LY, Rajabto W, Harano K, Hong SH, Malik RA, Strebel H, Aggarwal IM, Lai CH, Dejthevaporn T, Tangjitgamol S, Cheng WF, Chay WY, Benavides D, Hashim NM, Moon YW, Yunokawa M, Anggraeni TD, Wei W, Curigliano G, Maheshwari A, Mahantshetty U, Sheshadri S, Peters S, Yoshino T, Pentheroudakis G. Koppikar S, et al. Among authors: yoshino t. ESMO Open. 2023 Feb;8(1):100774. doi: 10.1016/j.esmoop.2022.100774. Epub 2023 Jan 23. ESMO Open. 2023. PMID: 36696825 Free PMC article.
Sequential Combination of FLAM and Venetoclax plus Azacitidine to Bridge to Cord Blood Transplantation in a Patient with Primary Induction Failure Acute Myeloid Leukemia.
Murakami H, Matsuoka KI, Asano T, Moriyama T, Matsumura A, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Toji T, Yoshino T, Maeda Y. Murakami H, et al. Among authors: yoshino t. Case Rep Oncol. 2022 Nov 8;15(3):974-979. doi: 10.1159/000526697. eCollection 2022 Sep-Dec. Case Rep Oncol. 2022. PMID: 36636684 Free PMC article.
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer.
Strickler JH, Bekaii-Saab T, Cercek A, Heinemann V, Nakamura Y, Raghav K, Siena S, Tabernero J, Van Cutsem E, Yoshino T, Ramos J, Guan X, Andre T. Strickler JH, et al. Among authors: yoshino t. Future Oncol. 2024 Dec 26:1-9. doi: 10.1080/14796694.2024.2441101. Online ahead of print. Future Oncol. 2024. PMID: 39723627 Free article.
A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device.
Bando H, Naito Y, Yamada T, Fujisawa T, Imai M, Sakamoto Y, Saigusa Y, Yamamoto K, Tomioka Y, Takeshita N, Sunami K, Futamura M, Notake C, Aoki S, Okano K, Yoshino T. Bando H, et al. Among authors: yoshino t. Int J Clin Oncol. 2024 Dec 23. doi: 10.1007/s10147-024-02684-z. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39714567 Review.
2,110 results